Name | Number of supported studies | Average coverage | |
---|---|---|---|
neuron | 5 studies | 46% ± 23% | |
Mueller cell | 5 studies | 79% ± 16% | |
GABAergic amacrine cell | 4 studies | 27% ± 13% | |
glycinergic amacrine cell | 4 studies | 22% ± 3% | |
amacrine cell | 4 studies | 41% ± 13% | |
fibroblast | 3 studies | 37% ± 13% | |
retinal ganglion cell | 3 studies | 39% ± 28% | |
astrocyte | 3 studies | 32% ± 8% | |
retina horizontal cell | 3 studies | 22% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
eye | 9 studies | 31% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 2912.92 | 651 / 653 | 58% | 55.44 | 353 / 605 |
spleen | 100% | 1515.43 | 240 / 241 | 0% | 0 | 0 / 0 |
brain | 82% | 639.15 | 2170 / 2642 | 15% | 6.50 | 103 / 705 |
ovary | 2% | 2.84 | 4 / 180 | 84% | 221.12 | 360 / 430 |
breast | 43% | 187.56 | 197 / 459 | 38% | 61.21 | 422 / 1118 |
kidney | 60% | 212.20 | 53 / 89 | 3% | 3.79 | 27 / 901 |
intestine | 43% | 94.40 | 411 / 966 | 8% | 2.85 | 42 / 527 |
stomach | 29% | 117.37 | 105 / 359 | 13% | 3.71 | 38 / 286 |
skin | 30% | 74.37 | 535 / 1809 | 9% | 11.32 | 44 / 472 |
uterus | 1% | 0.65 | 1 / 170 | 24% | 46.18 | 111 / 459 |
esophagus | 4% | 7.41 | 57 / 1445 | 17% | 3.32 | 31 / 183 |
prostate | 18% | 33.93 | 44 / 245 | 2% | 0.57 | 12 / 502 |
adrenal gland | 2% | 18.95 | 5 / 258 | 17% | 19.30 | 40 / 230 |
eye | 0% | 0 | 0 / 0 | 19% | 9.90 | 15 / 80 |
lung | 1% | 5.45 | 7 / 578 | 15% | 7.70 | 176 / 1155 |
tonsil | 0% | 0 | 0 / 0 | 11% | 12.83 | 5 / 45 |
bladder | 0% | 0 | 0 / 21 | 7% | 2.53 | 35 / 504 |
pancreas | 1% | 1.13 | 2 / 328 | 4% | 1.19 | 7 / 178 |
blood vessel | 4% | 13.67 | 52 / 1335 | 0% | 0 | 0 / 0 |
adipose | 2% | 5.93 | 24 / 1204 | 0% | 0 | 0 / 0 |
heart | 0% | 1.02 | 4 / 861 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 0% | 0.04 | 1 / 406 |
peripheral blood | 0% | 0.23 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_0015908 | Biological process | fatty acid transport |
GO_0005829 | Cellular component | cytosol |
GO_0005634 | Cellular component | nucleus |
GO_0019841 | Molecular function | retinol binding |
GO_0005501 | Molecular function | retinoid binding |
GO_0005504 | Molecular function | fatty acid binding |
GO_0016918 | Molecular function | retinal binding |
GO_0005515 | Molecular function | protein binding |
GO_0001972 | Molecular function | retinoic acid binding |
Gene name | CRABP1 |
Protein name | Cellular retinoic acid-binding protein 1 (Cellular retinoic acid-binding protein I) (CRABP-I) Cellular retinoic acid binding protein 1 Cellular retinoic acid-binding protein 1 (Cellular retinoic acid-binding protein I) |
Synonyms | hCG_38931 RBP5 |
Description | FUNCTION: Cytosolic CRABPs may regulate the access of retinoic acid to the nuclear retinoic acid receptors. FUNCTION: Cytosolic CRABPs may regulate the access of retinoic acid to the nuclear retinoic acid receptors. . |
Accessions | P29762 ENST00000406419.1 ENST00000299529.7 B5MCB5 F1T0F7 |